Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (281-290 of 715) with videos related to

Pageof 72
Sort By:
The Journal of Biological Chemistry|March 5, 1991
On the reversible interaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator and with urokinase-type plasminogen activatorH R Lijnen, B Van Hoef, D Collen
Circulation|March 1, 1993
Comparative immunogenicity and thrombolytic properties toward arterial and venous thrombi of streptokinase and recombinant staphylokinase in baboonsD Collen, F De Cock, J M Stassen
Biochimica Et Biophysica Acta|December 10, 1986
Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activatorH R Lijnen, B Van Hoef, D Collen
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1986
Biochemical and biological properties of single-chain urokinase-type plasminogen activatorD C Stump, H R Lijnen, D Collen
Thrombosis Research|January 1, 1979
A coagulo-radioimmunometric assay for the quantitation of fibrin monomer in human plasma. Principles and development of the methodJ Félez, E F Plow, B Wiman, et al.
Thrombosis Research|August 1, 1978
Effects of the synthetic fibrinolytic agents ortho-thymotic acid and S-1623 on the reaction between human plasmin and antiplasminM H Prandini, B Wiman, M Samama, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2000
Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery diseaseP Holvoet, J Van Cleemput, D Collen, et al.
Thrombosis Research|April 27, 2001
Matrix metalloproteinase deficiencies do not impair cell-associated fibrinolytic activityF Ugwu, G Lemmens, D Collen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 15, 2001
Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivationJ Silence, F Lupu, D Collen, et al.
The Journal of Biological Chemistry|January 25, 1986
Activation of plasminogen by pro-urokinase. II. KineticsD Collen, C Zamarron, H R Lijnen, et al.
Pageof 72

Showing results (281-290 of 715) with videos related to

Sort By:
Pageof 72
The Journal of Biological Chemistry|March 5, 1991
On the reversible interaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator and with urokinase-type plasminogen activatorH R Lijnen, B Van Hoef, D Collen
Circulation|March 1, 1993
Comparative immunogenicity and thrombolytic properties toward arterial and venous thrombi of streptokinase and recombinant staphylokinase in baboonsD Collen, F De Cock, J M Stassen
Biochimica Et Biophysica Acta|December 10, 1986
Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activatorH R Lijnen, B Van Hoef, D Collen
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1986
Biochemical and biological properties of single-chain urokinase-type plasminogen activatorD C Stump, H R Lijnen, D Collen
Thrombosis Research|January 1, 1979
A coagulo-radioimmunometric assay for the quantitation of fibrin monomer in human plasma. Principles and development of the methodJ Félez, E F Plow, B Wiman, et al.
Thrombosis Research|August 1, 1978
Effects of the synthetic fibrinolytic agents ortho-thymotic acid and S-1623 on the reaction between human plasmin and antiplasminM H Prandini, B Wiman, M Samama, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2000
Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery diseaseP Holvoet, J Van Cleemput, D Collen, et al.
Thrombosis Research|April 27, 2001
Matrix metalloproteinase deficiencies do not impair cell-associated fibrinolytic activityF Ugwu, G Lemmens, D Collen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 15, 2001
Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivationJ Silence, F Lupu, D Collen, et al.
The Journal of Biological Chemistry|January 25, 1986
Activation of plasminogen by pro-urokinase. II. KineticsD Collen, C Zamarron, H R Lijnen, et al.
Pageof 72